Jianqiang Wu

11PUBLICATIONS
36CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markersHaematologyCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 13, 2026
Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target.

|Sep 24, 2025
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas.

Niousha Ahmari, Kwangmin Choi, Jianqiang Wu

|Mar 08, 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.

Melissa R Perrino, Niousha Ahmari, Ashley Hall

|Feb 27, 2023
Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.

Mark Jackson, Niousha Ahmari, Jianqiang Wu

|Feb 09, 2023
Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis.

Youjin Na, Ashley Hall, Yanan Yu

|Jan 20, 2023
A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation.

Chen Wang, Zhaowei Tu, Xiongwei Cai

Pageof 2

Frequent Collaborators

5 joint publications

Nancy Ratner

4 joint publications

Eva Dombi

3 joint publications

Kwangmin Choi

3 joint publications

MiOk Kim